Yervoy and Epinastine hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Yervoy (ipilimumab) and Epinastine hydrochloride (epinastine hydrochloride). Common drug interactions include adrenocortical insufficiency acute among males.

The phase IV clinical study analyzes what interactions people have when they take Yervoy and Epinastine hydrochloride. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Yervoy?

Yervoy has active ingredients of ipilimumab. eHealthMe is studying from 26,662 Yervoy users. Check the latest studies of Yervoy.

What is Epinastine hydrochloride?

Epinastine hydrochloride has active ingredients of epinastine hydrochloride. eHealthMe is studying from 1,582 Epinastine hydrochloride users. Check the latest studies of Epinastine hydrochloride.

On Jul, 12, 2026

14 people who take Yervoy and Epinastine hydrochloride together, and have interactions are studied.

Yervoy and Epinastine hydrochloride drug interactions.

What are the common drug interactions of Yervoy and Epinastine Hydrochloride, by gender? *:

female:

n/a

male:

Adrenocortical insufficiency acute (suddenly adrenal glands do not produce adequate amounts of steroid hormones)
Altered state of consciousness (altered state of mind)
Tumour haemorrhage (bleeding from tumour)
Cytomegalovirus enterocolitis (virus infection of intestine and colon)
Polymyalgia rheumatica (pain in many muscles)
Nephrotic syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Death
Device related infection
Encephalitis (inflammation of the brain)

What are the common drug interactions of Yervoy and Epinastine Hydrochloride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
Platelet count decreased
Speech disorder
Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
Tumour haemorrhage (bleeding from tumour)
Altered state of consciousness (altered state of mind)
Device related infection
Encephalitis (inflammation of the brain)

60+:

Adrenocortical insufficiency acute (suddenly adrenal glands do not produce adequate amounts of steroid hormones)
Death
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Cytomegalovirus enterocolitis (virus infection of intestine and colon)
Polymyalgia rheumatica (pain in many muscles)
Nephrotic syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

What are the existing conditions these people have? *

Renal Cell Carcinoma (a kidney cancer): 10 people, 71.43%
Renal Cancer Recurrent (cancer of kidney repeat): 2 people, 14.29%
Lung Cancer - Non-Small Cell (lung cancer): 2 people, 14.29%
Nausea (feeling of having an urge to vomit): 1 person, 7.14%
Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Yervoy and Epinastine hydrochloride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously